General Information of This Antibody-drug Conjugate (ADC)
ADC ID
DRG0BEPPD
ADC Name
ADC project 7 (Suzhou Medilink Therapeutics Ltd.)
Synonyms
Project 7 (Suzhou Medilink Therapeutics Ltd.)
   Click to Show/Hide
Organization
Suzhou Medilink Therapeutics Ltd.
Drug Status
Investigative
Indication
In total 1 Indication(s)
Solid tumors [ICD11:2A00-2A0Z|2B50-2F9Z]
Investigative
Antibody Name
Undisclosed
Antigen Name
Undisclosed
Payload Name
Undisclosed
Linker Name
Undisclosed
Conjugate Type
TMALIN platform.

If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.